MGMT and glioblastoma: The meta-analysis of a large number of literature data showed that patients with a methylated status of MGMT receiving temozolomide treatment had better overall survival and progression-free survival, but not significant advantage on overall survival or progression-free survival in glioblastoma patients not treated with temozolomide.